The Patent Finder

Polymerase Variants

Roche Sequencing Solutions, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 6 of these applications claim priority to application 62/161,571, filed May 14, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,526,588Polymerase Variants and Uses Thereof
In force
 · High confidence
UsedRemaining
Roche Sequencing Solutions, Inc.In forceHigh confidence
US 10,612,009Polymerase Variants
In force
 · High confidence
Roche Sequencing Solutions, Inc.In forceHigh confidence
US 10,961,520Polymerase Variants
In force
 · High confidence
Roche Molecular Systems, Inc.In forceHigh confidence
US 10,968,438Polymerase Variants and Uses Thereof
In force
 · High confidence
Roche Sequencing Solutions, Inc.In forceHigh confidence
US 11,788,073Polymerase Variants and Uses Thereof
In force
 · High confidence
Roche Sequencing Solutions, Inc.In forceHigh confidence
US 10,308,918Polymerase Variants
In force
 · High confidence
Roche Sequencing Solutions, Inc.In forceHigh confidence
Application 17/249,607Polymerase Variants
Abandoned
Abandoned May 11, 2023
Roche Molecular Systems, Inc.AbandonedAbandoned May 11, 2023
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Roche Sequencing Solutions, Inc..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited